GROWTH EQUITY OPPORTUNITIES FUND III, LLC (AURINIA) - SCHEDULE 13DA1E

Company

Aurinia Pharmaceuticals Inc.

Filed

March 11, 2021

Accession Number

0001072613-21-000299